Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System

The Liposomal Encapsulation of Polysaccharides (LEPS) dual antigen vaccine carrier system was assessed across two distinct polysaccharides for encapsulation efficiency, subsequent liposomal surface adornment with protein, adjuvant addition, and size and charge metrics. The polysaccharides derive fro...

Full description

Bibliographic Details
Main Authors: Roozbeh Nayerhoda, Dongwon Park, Charles Jones, Elsa N. Bou Ghanem, Blaine A. Pfeifer
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Materials
Subjects:
Online Access:https://www.mdpi.com/1996-1944/13/15/3320
_version_ 1797561316339089408
author Roozbeh Nayerhoda
Dongwon Park
Charles Jones
Elsa N. Bou Ghanem
Blaine A. Pfeifer
author_facet Roozbeh Nayerhoda
Dongwon Park
Charles Jones
Elsa N. Bou Ghanem
Blaine A. Pfeifer
author_sort Roozbeh Nayerhoda
collection DOAJ
description The Liposomal Encapsulation of Polysaccharides (LEPS) dual antigen vaccine carrier system was assessed across two distinct polysaccharides for encapsulation efficiency, subsequent liposomal surface adornment with protein, adjuvant addition, and size and charge metrics. The polysaccharides derive from two different serotypes of <i>Streptococcus pneumoniae</i> and have traditionally served as the active ingredients of vaccines against pneumococcal disease. The LEPS system was designed to mimic glycoconjugate vaccines that covalently couple polysaccharides to protein carriers; however, the LEPS system uses a noncovalent co-localization mechanism through protein liposomal surface attachment. In an effort to more thoroughly characterize the LEPS system across individual vaccine components and thus support broader future utility, polysaccharides from <i>S. pneumoniae</i> serotypes 3 and 4 were systematically compared within the LEPS framework both pre- and post-surface protein attachment. For both polysaccharides, ≥85% encapsulation efficiency was achieved prior to protein surface attachment. Upon protein attachment with either a model protein (GFP) or a pneumococcal disease antigen (PncO), polysaccharide encapsulation was maintained at ≥61% encapsulation efficiency. Final LEPS carriers were also evaluated with and without alum as an included adjuvant, with encapsulation efficiency maintained at ≥30%, while protein surface attachment efficiency was maintained at ≥~50%. Finally, similar trends and distributions were observed across the different polysaccharides when assessed for liposomal zeta potential and size.
first_indexed 2024-03-10T18:12:11Z
format Article
id doaj.art-8c2d20b5c79145a2892b040f716e696a
institution Directory Open Access Journal
issn 1996-1944
language English
last_indexed 2024-03-10T18:12:11Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Materials
spelling doaj.art-8c2d20b5c79145a2892b040f716e696a2023-11-20T07:59:59ZengMDPI AGMaterials1996-19442020-07-011315332010.3390/ma13153320Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides SystemRoozbeh Nayerhoda0Dongwon Park1Charles Jones2Elsa N. Bou Ghanem3Blaine A. Pfeifer4Department of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USADepartment of Chemical and Biological Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USAAbcombi Biosciences Inc., 1576 Sweet Home Road, Amherst, NY 14260, USADepartment of Microbiology and Immunology, University at Buffalo, The State University of New York, Buffalo, NY 14260, USADepartment of Biomedical Engineering, University at Buffalo, The State University of New York, Buffalo, NY 14260, USAThe Liposomal Encapsulation of Polysaccharides (LEPS) dual antigen vaccine carrier system was assessed across two distinct polysaccharides for encapsulation efficiency, subsequent liposomal surface adornment with protein, adjuvant addition, and size and charge metrics. The polysaccharides derive from two different serotypes of <i>Streptococcus pneumoniae</i> and have traditionally served as the active ingredients of vaccines against pneumococcal disease. The LEPS system was designed to mimic glycoconjugate vaccines that covalently couple polysaccharides to protein carriers; however, the LEPS system uses a noncovalent co-localization mechanism through protein liposomal surface attachment. In an effort to more thoroughly characterize the LEPS system across individual vaccine components and thus support broader future utility, polysaccharides from <i>S. pneumoniae</i> serotypes 3 and 4 were systematically compared within the LEPS framework both pre- and post-surface protein attachment. For both polysaccharides, ≥85% encapsulation efficiency was achieved prior to protein surface attachment. Upon protein attachment with either a model protein (GFP) or a pneumococcal disease antigen (PncO), polysaccharide encapsulation was maintained at ≥61% encapsulation efficiency. Final LEPS carriers were also evaluated with and without alum as an included adjuvant, with encapsulation efficiency maintained at ≥30%, while protein surface attachment efficiency was maintained at ≥~50%. Finally, similar trends and distributions were observed across the different polysaccharides when assessed for liposomal zeta potential and size.https://www.mdpi.com/1996-1944/13/15/3320liposomeserotypepolysaccharide<i>Streptococcus pneumoniae</i>vaccinepneumococcal disease
spellingShingle Roozbeh Nayerhoda
Dongwon Park
Charles Jones
Elsa N. Bou Ghanem
Blaine A. Pfeifer
Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System
Materials
liposome
serotype
polysaccharide
<i>Streptococcus pneumoniae</i>
vaccine
pneumococcal disease
title Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System
title_full Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System
title_fullStr Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System
title_full_unstemmed Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System
title_short Extended Polysaccharide Analysis within the Liposomal Encapsulation of Polysaccharides System
title_sort extended polysaccharide analysis within the liposomal encapsulation of polysaccharides system
topic liposome
serotype
polysaccharide
<i>Streptococcus pneumoniae</i>
vaccine
pneumococcal disease
url https://www.mdpi.com/1996-1944/13/15/3320
work_keys_str_mv AT roozbehnayerhoda extendedpolysaccharideanalysiswithintheliposomalencapsulationofpolysaccharidessystem
AT dongwonpark extendedpolysaccharideanalysiswithintheliposomalencapsulationofpolysaccharidessystem
AT charlesjones extendedpolysaccharideanalysiswithintheliposomalencapsulationofpolysaccharidessystem
AT elsanboughanem extendedpolysaccharideanalysiswithintheliposomalencapsulationofpolysaccharidessystem
AT blaineapfeifer extendedpolysaccharideanalysiswithintheliposomalencapsulationofpolysaccharidessystem